|
1.
|
Johnson RJ, Kurokawa K and Bakris GL:
Pathogenesis and clinical course of essential hypertension.
Comprehensive Clinical Nephrology. Johnson RJ and Feehally J: 1st
edition. Harcourt Publishers; Philadelphia: pp. 12000
|
|
2.
|
Hill GS: Hypertensive nephrosclerosis.
Curr Opin Nephrol Hypertens. 17:266–270. 2008. View Article : Google Scholar
|
|
3.
|
Helmchen U: Effects of hypertension on
renal vasculature and structure. Oxford Textbook of Clinical
Nephrology. Cameron S, Davison AM and Grünfeld JP: Oxford
University Press; Oxford: pp. 20751992
|
|
4.
|
Marín R, Gorostidi M, Fernández-Vega F and
Alvarez-Navascués R: Systemic and glomerular hypertension and
progression of chronic renal disease: the dilemma of
nephrosclerosis. Kidney Int Suppl. 99:S52–S56. 2005.PubMed/NCBI
|
|
5.
|
Izzo JL Jr and Black HR: Hypertension
primer: The Essentials of High Blood Pressure. Council on High
Blood Pressure Research, American Heart Association; Dallas, TX:
pp. 31993
|
|
6.
|
Tso MO and Jampol LM: Pathophysiology of
hypertensive retinopathy. Ophthalmology. 89:1132–1145. 1982.
View Article : Google Scholar
|
|
7.
|
Hansson LH: The effect of dihydropyridine
calcium antagonists in hypertensive patients with impaired renal
function. J Cardiovasc Pharmacol. 14(Suppl 10): S36–S39; discussion
S59–S62. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Masuo K: Obesity-related hypertenion: role
of the sympathetic nervous systerm, insulin, and leptin. Curr
Hypertens Rep. 4:112–118. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Heim A, Pasche A, Feihl F, Liaudet L and
Waeber B: Hypertension: early detection of target organ damage. Rev
Med Suisse. 3:1996, 2007.(In French).
|
|
10.
|
Mulè G, Cottone S, Cusimano P, et al:
Inverse relationship between ambulatory arterial stiffness index
and glomerular filtration rate in arterial hypertension. Am J
Hypertens. 21:35–40. 2008.PubMed/NCBI
|
|
11.
|
Romain TM, Patel RP, Heaberlin AM and
Zarowitz BJ: Assessment of factors in influencing blood pressure
control in a managed care population. Pharmacotherapy.
23:1060–1070. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Redon J and Pascual JM: Development of
microalbuminuria in essential hypertension. Curr Hypertens Rep.
8:171–177. 2006. View Article : Google Scholar
|
|
13.
|
Lea J, Greene T, Hebert L, et al: The
relationship between magnitude of proteinuria reduction and risk of
end-stage renal disease: results of the African American study of
kidney disease and hypertension. Arch Intern Med. 165:947–953.
2005. View Article : Google Scholar
|
|
14.
|
Menè P and Punzo G: Uric acid: bystander
or culprit in hypertension and progressive renal disease? J
Hypertens. 26:2085–2092. 2008.PubMed/NCBI
|
|
15.
|
Flack JM, Peter R, Shafi T, Alrefai H,
Nasser SA and Crook E: Prevention of hypertension and its
complications: theoretical basis and guidelines for treatment. J Am
Soc Nephrol. 14(Suppl 2): S92–S98. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ikee R, Kobayashi S, Saigusa T, et al:
Impact of hypertension and hypertension-related vascular lesions in
IgA nephropathy. Hypertens Res. 29:15–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Epstein M and Calhoun DA: The role of
aldosterone in resistant hypertension: implications for
pathogenesis and therapy. Curr Hypertens Rep. 9:98–105. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Barrett-O’Keefe Z, Witman MA, McDaniel J,
et al: Angiotensin II potentiates α-adrenergic vasoconstriction in
the elderly. Clin Sci (Lond). 124:413–422. 2013.
|
|
19.
|
Yui Y, Kodama K, Hirayama A, Hosoda S and
Kawai C; Japan Multicenter Investigation for Cardiovascular
DiseaseB (JMIC-B) Study Group: Estimated glomerular filtration rate
reversal by blood pressure lowering in chronic kidney disease:
Japan Multicenter Investigation for Cardiovascular DiseaseB CKD
study. J Clin Hypertens (Greenwich). 15:171–175. 2013. View Article : Google Scholar
|
|
20.
|
Poudel B, Yadav BK, Shrestha R, Mittal A,
Jha B and Raut KB: Assessment of chronic kidney disease in Nepalese
people with hypertension. Nepal Med Coll J. 14:25–30.
2012.PubMed/NCBI
|
